Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
February-2022 Volume 25 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2022 Volume 25 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats

  • Authors:
    • Hui Chen
    • Jinfeng Cui
    • Juan Wang
    • Yuan Wang
    • Fei Tong
    • Yingping Tian
    • Yu Gong
    • Yu Ma
    • Liang Liu
    • Xianghong Zhang
  • View Affiliations / Copyright

    Affiliations: Emergency Department, The Second Hospital, Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Pathology, The Second Hospital, Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China
  • Article Number: 58
    |
    Published online on: December 15, 2021
       https://doi.org/10.3892/mmr.2021.12574
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Pulmonary fibrosis is one of the most important pathological processes associated with paraquat (PQ) poisoning. 5‑Aminosalicylic acid (5‑ASA) has been shown to be a promising agent against fibrotic diseases. In the present study, the alleviating role of 5‑ASA was evaluated in a rat model of pulmonary fibrosis induced by PQ intragastric poisoning (80 mg/kg). Wistar rats were divided into control, PQ, 5‑ASA (30 mg/kg daily, 14 days) and PQ + 5‑ASA groups. Histological examination revealed congestion, edema and inflammatory cell infiltration in the bronchial and alveolar walls at 3 days after PQ exposure. Alveolar septum thickening with alveolar lumen narrowing was observed at 14 days, while fibroblast proliferation, increase in collagen fiber number and fibrous thickening of the alveolar walls were observed at 28 day. All the aforementioned pulmonary injury changes in the PQ group were attenuated in the PQ + 5‑ASA group. Hydroxyproline (HYP) content increased in the lung tissues of the rats at 14 days after PQ treatment and reached a peak at 28 days. Compared with the PQ group, HYP contents of lung tissue decreased at 14 and 28 days after PQ + 5‑ASA treatment. Masson's trichrome staining revealed that the increase in the amount of collagen fibers in the lung tissues of rats in the PQ group was inhibited by 5‑ASA treatment, further confirming the alleviating effect of 5‑ASA on fibrosis. In addition, the results showed that 5‑ASA attenuated the upregulation of transforming growth factor‑β1 and phosphorylated‑SMAD3, and the reduction of peroxisome proliferator activated receptor γ induced by PQ in lung tissue of rats and human lung fibroblast WI‑38 VA13 cells. In conclusion, the results suggested that 5‑ASA had an alleviating effect on PQ‑induced pulmonary fibrosis, partly by suppressing the activation of the TGF‑β1 signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

View References

1 

Sun B and Chen YG: Advances in the mechanism of paraquat-induced pulmonary injury. Eur Rev Med Pharmacol Sci. 20:1597–1602. 2016.PubMed/NCBI

2 

Zhou Q, Kan B, Jian X, Zhang W, Liu H and Zhang Z: Paraquat poisoning by skin absorption: Two case reports and a literature review. Exp Ther Med. 6:1504–1506. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Kimbrough RD and Linder RE: The ultrastructure of the paraquat lung lesion in the rat. Environ Res. 6:265–273. 1973. View Article : Google Scholar : PubMed/NCBI

4 

Shadnia S, Ebadollahi-Natanzi A, Ahmadzadeh S, Karami-Mohajeri S, Pourshojaei Y and Rahimi HR: Delayed death following paraquat poisoning: Three case reports and a literature review. Toxicol Res (Camb). 7:745–753. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Tsoyi K, Chu SG, Patino-Jaramillo NG, Wilder J, Villalba J, Doyle-Eisele M, McDonald J, Liu X, El-Chemaly S, Perrella MA and Rosas IO: Syndecan-2 Attenuates Radiation-induced pulmonary fibrosis and inhibits fibroblast activation by regulating PI3K/Akt/ROCK Pathway via CD148. Am J Respir Cell Mol Biol. 58:208–215. 2018. View Article : Google Scholar : PubMed/NCBI

6 

Kan B, Jian X, Zhou Q, Wang J, Yu G, Sun J and Gao Y: Effect of transforming growth factor-beta1 on acute lung injury caused by paraquat. Mol Med Rep. 9:1232–1236. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Han YY, Shen P and Chang WX: Involvement of epithelial-to-mesenchymal transition and associated transforming growth factor-β/Smad signaling in paraquat-induced pulmonary fibrosis. Mol Med Rep. 12:7979–7984. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Hua XF, Li XH, Li MM, Zhang CY, Liu HJ, Sun T, Zhou HG and Yang C: Doxycycline attenuates paraquat-induced pulmonary fibrosis by downregulating the TGF-β signaling pathway. J Thorac Dis. 9:4376–4386. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Ren Y, Jian X, Zhang Z, Ning Q, Kan B and Kong L: Effects of tacrolimus on the TGF-β1/SMAD signaling pathway in paraquat-exposed rat alveolar type II epithelial cells. Mol Med Rep. 22:3687–3694. 2020.PubMed/NCBI

10 

Hu Z, Qin F, Gao S, Zhen Y, Huang D and Dong L: Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-β1/Smads signaling pathway. Am J Transl Res. 10:1012–1021. 2018.eCollection 2018. PubMed/NCBI

11 

Sato M, Muragaki Y, Saika S, Roberts AB and Ooshima A: Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest. 112:1486–1494. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Loboda A, Sobczak M, Jozkowicz A and Dulak J: TGF-β1/Smads and miR-21 in renal fibrosis and inflammation. Mediators Inflamm. 2016:83192832016. View Article : Google Scholar : PubMed/NCBI

13 

Sisto M, Lorusso L, Ingravallo G, Tamma R, Ribatti D and Lisi S: The TGF-β1 signaling pathway as an attractive target in the fibrosis pathogenesis of Sjogren's Syndrome. Mediators Inflamm. 2018:19659352018. View Article : Google Scholar : PubMed/NCBI

14 

Ramirez A, Ballard EN and Roman J: TGFβ1 Controls PPARү expression, transcriptional potential, and activity, in part, through Smad3 Signaling in Murine lung fibroblasts. PPAR Res. 2012:3758762012. View Article : Google Scholar : PubMed/NCBI

15 

Calvier L, Chouvarine P, Legchenko E, Hoffmann N, Geldner J, Borchert P, Jonigk D, Mozes MM and Hansmann G: PPARү Links BMP2 and TGFβ1 pathways in vascular smooth muscle cells, regulating cell proliferation and glucose metabolism. Cell Metab. 25:1118–1134.e7. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Solitano V, D'Amico F, Fiorino G, Paridaens K, Peyrin-Biroulet L and Danese S: Key strategies to optimize outcomes in Mild-to-Moderate Ulcerative Colitis. J Clin Med. 9:29052020. View Article : Google Scholar : PubMed/NCBI

17 

Le Berre C, Roda G, Nedeljkovic Protic M, Danese S and Peyrin-Biroulet L: Modern use of 5-aminosalicylic acid compounds for ulcerative colitis. Expert Opin Biol Ther. 20:363–378. 2020. View Article : Google Scholar : PubMed/NCBI

18 

Cevallos SA, Lee JY, Velazquez EM, Foegeding NJ, Shelton CD, Tiffany CR, Parry BH, Stull-Lane AR, Olsan EE, Savage HP, et al: 5-Aminosalicylic Acid Ameliorates Colitis and checks Dysbiotic Escherichia coli expansion by activating PPAR-γ Signaling in the intestinal epithelium. mBio. 12:e03227–20. 2021. View Article : Google Scholar : PubMed/NCBI

19 

Vetuschi A, Pompili S, Gaudio E, Latella G and Sferra R: PPAR-γ with its anti-inflammatory and anti-fibrotic action could be an effective therapeutic target in IBD. Eur Rev Med Pharmacol Sci. 22:8839–8848. 2018.PubMed/NCBI

20 

Rousseaux C, El-Jamal N, Fumery M, Dubuquoy C, Romano O, Chatelain D, Langlois A, Bertin B, Buob D, Colombel JF, et al: The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ. Carcinogenesis. 34:2580–2586. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Wang Z, Koonen D, Hofker M and Bao Z: 5-aminosalicylic acid improves lipid profile in mice fed a high-fat cholesterol diet through its dual effects on intestinal PPARgamma and PPARalpha. PLoS One. 13:e01914852018. View Article : Google Scholar : PubMed/NCBI

22 

Wang Y, Zhou M, Lu Y, Yu A and Li J: Protective effect of 5-aminosalicylic acid on the kidney of paraquat poisoning rats by Nrf2-ARE signal pathway. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 29:961–966. 2017.(In Chinese). PubMed/NCBI

23 

Ramadan A, Afifi N, Yassin NZ, Abdel-Rahman RF, Abd El-Rahman SS and Fayed HM: Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats. Chem Biol Interact. 289:109–118. 2018. View Article : Google Scholar : PubMed/NCBI

24 

Hoffmann M, Kant TA, Emig R, Rausch JSE, Newe M, Schubert M, Künzel K, Winter L, Klapproth E, Peyronnet R, et al: Repurposing mesalazine against cardiac fibrosis in vitro. Naunyn Schmiedebergs Arch Pharmacol. 394:533–543. 2021. View Article : Google Scholar : PubMed/NCBI

25 

Schaeffer WI: Proposed usage of animal tissue culture terms (revised 1978). Usage of vertebrate cell, tissue and organ culture terminology. In Vitro. 15:649–653. 1979. View Article : Google Scholar : PubMed/NCBI

26 

Zheng L, Zhang YL, Dai YC, Chen X, Chen DL, Dai YT and Tang ZP: Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-ΚB activation. World J Gastroenterol. 23:1180–1188. 2017. View Article : Google Scholar : PubMed/NCBI

27 

Tang H, Xiang D, Wang F, Mao J, Tan X and Wang Y: 5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice. Mol Med Rep. 15:1117–1122. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW and Crystal RG: Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis. 120:893–899. 1979.PubMed/NCBI

29 

Wei J, Ghosh AK, Sargent JL, Komura K, Wu M, Huang QQ, Jain M, Whitfield ML, Feghali-Bostwick C and Varga J: PPARү downregulation by TGFβ in fibroblast and impaired expression and function in systemic sclerosis: A novel mechanism for progressive fibrogenesis. PLoS One. 5:e137782010. View Article : Google Scholar : PubMed/NCBI

30 

Zhang Z, Ding L, Wu L, Xu L, Zheng L and Huang X: Salidroside alleviates paraquat-induced rat acute lung injury by repressing TGF-β1 expression. Int J Clin Exp Pathol. 7:8841–8847. 2014.eCollection 2014. PubMed/NCBI

31 

Srivastava AK, Khare P, Nagar HK, Raghuwanshi N and Srivastava R: Hydroxyproline: A potential biochemical marker and its role in the pathogenesis of different diseases. Curr Protein Pept Sci. 17:596–602. 2016. View Article : Google Scholar : PubMed/NCBI

32 

Kuhn C and McDonald JA: The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol. 138:1257–1265. 1991.PubMed/NCBI

33 

Pache JC, Christakos PG, Gannon DE, Mitchell JJ, Low RB and Leslie KO: Myofibroblasts in diffuse alveolar damage of the lung. Mod Pathol. 11:1064–1070. 1998.PubMed/NCBI

34 

Dong J, Yu X, Porter DW, Battelli LA, Kashon ML and Ma Q: Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents. Arch Toxicol. 90:385–402. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Zhou H, Yu X and Zhou G: NLRC5 silencing ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway. Mol Med Rep. 16:3551–3556. 2017. View Article : Google Scholar : PubMed/NCBI

36 

Xue L, Zhang X, Li Y, Yang H, Li X, Mi J, Wang H, Wang J and Yan X: Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach. Hum Pathol. 42:594–601. 2011. View Article : Google Scholar : PubMed/NCBI

37 

Liu Y, Wang J, Luo S, Zhan Y and Lu Q: The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review. J Autoimmun. 113:1025102020. View Article : Google Scholar : PubMed/NCBI

38 

Carvalho MV, Goncalves-de-Albuquerque CF and Silva AR: PPAR Gamma: From definition to molecular targets and therapy of lung diseases. Int J Mol Sci. 22:8052021. View Article : Google Scholar : PubMed/NCBI

39 

Kulkarni AA, Thatcher TH, Olsen KC, Maggirwar SB, Phipps RP and Sime PJ: PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: Implications for therapy of fibrosis. PLoS One. 6:e159092011. View Article : Google Scholar : PubMed/NCBI

40 

Moran CJ, Huang H, Rivas M, Kaplan JL, Daly MJ and Winter HS: Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis. PLoS One. 13:e01928062018. View Article : Google Scholar : PubMed/NCBI

41 

Serra D, Almeida LM and Dinis TC: Anti-inflammatory protection afforded by cyanidin-3-glucoside and resveratrol in human intestinal cells via Nrf2 and PPAR-γ: Comparison with 5-aminosalicylic acid. Chem Biol Interact. 260:102–109. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen H, Cui J, Wang J, Wang Y, Tong F, Tian Y, Gong Y, Ma Y, Liu L, Zhang X, Zhang X, et al: 5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats. Mol Med Rep 25: 58, 2022.
APA
Chen, H., Cui, J., Wang, J., Wang, Y., Tong, F., Tian, Y. ... Zhang, X. (2022). 5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats. Molecular Medicine Reports, 25, 58. https://doi.org/10.3892/mmr.2021.12574
MLA
Chen, H., Cui, J., Wang, J., Wang, Y., Tong, F., Tian, Y., Gong, Y., Ma, Y., Liu, L., Zhang, X."5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats". Molecular Medicine Reports 25.2 (2022): 58.
Chicago
Chen, H., Cui, J., Wang, J., Wang, Y., Tong, F., Tian, Y., Gong, Y., Ma, Y., Liu, L., Zhang, X."5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats". Molecular Medicine Reports 25, no. 2 (2022): 58. https://doi.org/10.3892/mmr.2021.12574
Copy and paste a formatted citation
x
Spandidos Publications style
Chen H, Cui J, Wang J, Wang Y, Tong F, Tian Y, Gong Y, Ma Y, Liu L, Zhang X, Zhang X, et al: 5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats. Mol Med Rep 25: 58, 2022.
APA
Chen, H., Cui, J., Wang, J., Wang, Y., Tong, F., Tian, Y. ... Zhang, X. (2022). 5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats. Molecular Medicine Reports, 25, 58. https://doi.org/10.3892/mmr.2021.12574
MLA
Chen, H., Cui, J., Wang, J., Wang, Y., Tong, F., Tian, Y., Gong, Y., Ma, Y., Liu, L., Zhang, X."5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats". Molecular Medicine Reports 25.2 (2022): 58.
Chicago
Chen, H., Cui, J., Wang, J., Wang, Y., Tong, F., Tian, Y., Gong, Y., Ma, Y., Liu, L., Zhang, X."5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats". Molecular Medicine Reports 25, no. 2 (2022): 58. https://doi.org/10.3892/mmr.2021.12574
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team